"Quest Diagnostics is committed to helping increase the number of people getting screened annually for colorectal cancer -- and the launch of InSure Quik F I T, alongside our national challenge called 'Do You Have The Guts,' can help to do just that," said Stephen C. Suffin, M.D., corporate clinical pathologist and interim chief laboratory officer, Quest Diagnostics. "The availability of InSure Quik F I T reinforces two of our company's priorities - - providing physicians and patients with diagnostic insights that can help improve preventive care, and improving and simplifying patient care with a growing portfolio of point-of-care testing options. Colorectal cancer is often treatable and even preventable when caught early, which is why annual screening with the InSure Quik F I T test is so important."
FIT tests detect blood in the stool that might indicate colorectal cancer or other lower gastrointestinal diseases. FIT tests help identify individuals that are candidates for colonoscopy, even if they do not have overt symptoms of colorectal cancer. This may mean the disease is in its early, more treatable stages, or that they may have precancerous polyps that can be removed during colonoscopy.
In addition to sensitivity and specificity, the unique features of the InSure family of tests have been shown to increase patient compliance with annual colorectal cancer screening programs. InSure FIT and InSure Quik F I T feature a unique long-handled blue brush to collect two water-based samples -- rather than the solid samples required by other FIT or FOBT tests. In addition, InSure Quik F I T does not require any change in patient diet or medication, enhancing its ease of use. In one study, patients were 66% more compliant in completing their InSure test compared to a leading guaiac-based FOBT test.(5)
To further encourage patient participation in yearly colorectal cancer
screening, Quest Diagnostics recently launched an innovative, online
|SOURCE Quest Diagnostics|
Copyright©2008 PR Newswire.
All rights reserved